Bahl and Gaynor Income Growth FundAFNIX
Type
Mutual fund
Peer group
US equity: large companies
Net assets
$1.7B
Expense ratio
0.63%
1-year return
+11.9%
3 years, a year
+11.7%
5 years, a year
+9.7%
Holdings
50
What it aims to do.
The investment objectives of the Bahl & Gaynor Income Growth Fund (the Fund) are primarily current and growing income,
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co | 5.66% |
| JNJ Johnson & Johnson | 5.28% |
| AVGO Broadcom Inc | 5.12% |
| ABBV AbbVie Inc | 4.63% |
| MSFT Microsoft Corp | 4.57% |
| TRV Travelers Cos Inc/The | 3.58% |
| JPM JPMorgan Chase & Co | 3.22% |
| WMB Williams Cos Inc/The | 2.94% |
| PG Procter & Gamble Co/The | 2.92% |
| NEE NextEra Energy Inc | 2.78% |
More on AFNIX.
- AFNIX overview
- AFNIX holdings
- AFNIX risk
- AFNIX costs
- AFNIX money in and out
- AFNIX share classes
- Compare AFNIX with other funds
Returns after fees, from the fund's SEC filings up to Dec 2025. Past returns are not a promise. Not financial advice.